Stefan Janssens Selected Research

Stefan Janssens Research Topics

Disease

24	Heart Failure 10/2022 - 02/2009
16	Myocardial Infarction 01/2021 - 05/2004
13	Infarction (Infarctions) 09/2018 - 01/2006
8	Cardiomyopathies (Cardiomyopathy) 01/2022 - 03/2008
7	Myocardial Ischemia (Ischemic Heart Diseases) 06/2017 - 05/2005
5	Stroke (Strokes) 10/2022 - 06/2013
5	Inflammation (Inflammations) 01/2022 - 10/2002
5	Heart Diseases (Heart Disease) 01/2022 - 08/2014
5	Left Ventricular Dysfunction 12/2019 - 01/2006
5	Hypertension (High Blood Pressure) 12/2017 - 07/2008
5	Atherosclerosis 08/2017 - 08/2002
4	Neoplasms (Cancer) 10/2022 - 11/2005
4	Cardiotoxicity 01/2022 - 06/2012
4	Diabetes Mellitus 01/2021 - 06/2013
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 06/2006
4	Ventricular Remodeling 01/2019 - 07/2007
4	ST Elevation Myocardial Infarction 04/2014 - 01/2006
4	Neointima 08/2009 - 06/2002
3	Cardiogenic Shock 01/2022 - 09/2003
3	Fibrosis (Cirrhosis) 01/2021 - 08/2005
3	Cicatrix (Scar) 01/2021 - 03/2008
3	Heart Arrest (Cardiac Arrest) 01/2020 - 01/2009
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 10/2002
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2018 - 06/2011
3	Pulmonary Hypertension 01/2018 - 04/2006
3	Obesity 01/2017 - 12/2009
3	Hypoxia (Hypoxemia) 04/2008 - 04/2006
3	Pathologic Constriction (Stenosis) 12/2007 - 06/2002
2	Acute Coronary Syndrome 10/2022 - 01/2018
2	Venous Thrombosis (Deep-Vein Thrombosis) 03/2022 - 06/2021
2	Atrial Fibrillation 01/2022 - 05/2013
2	Pathologic Processes 01/2022 - 01/2022
2	Chronic Renal Insufficiency 01/2020 - 01/2019
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 06/2013
2	Aortic Valve Stenosis (Aortic Stenosis) 12/2018 - 09/2013
2	Pulmonary Arterial Hypertension 12/2017 - 02/2014
2	Hypertrophy 09/2014 - 05/2004
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2013 - 07/2012
2	Weight Loss (Weight Reduction) 07/2012 - 12/2009
2	Vascular System Injuries 08/2009 - 02/2006
2	Vascular Remodeling 08/2007 - 04/2006
2	Hypercholesterolemia 10/2002 - 08/2002
1	Transient Ischemic Attack 10/2022
1	Heart Valve Diseases (Valvular Heart Disease) 10/2022
1	Myocarditis (Carditis) 10/2022
1	Optic Nerve Diseases (Optic Neuropathy) 08/2022
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 08/2022
1	Glaucoma 08/2022
1	COVID-19 03/2022
1	Critical Illness (Critically Ill) 01/2022
1	Hypotension (Low Blood Pressure) 10/2021
1	Urinary Tract Infections (Urinary Tract Infection) 10/2021

Drug/Important Bio-Agent (IBA)

9	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2017 - 05/2004
7	Biomarkers (Surrogate Marker)IBA 11/2020 - 06/2008
6	CollagenIBA 01/2022 - 08/2002
6	Nitric Oxide Synthase (NO Synthase)IBA 12/2017 - 05/2004
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2002
4	Guanosine Monophosphate (5' Guanylic Acid)IBA 12/2021 - 06/2002
4	sacubitril and valsartan sodium hydrate drug combinationIBA 11/2021 - 01/2018
4	empagliflozinIBA 11/2021 - 10/2020
4	C-Reactive ProteinIBA 06/2021 - 10/2002
4	Pharmaceutical PreparationsIBA 04/2018 - 01/2011
3	omega-Chloroacetophenone (Mace)IBA 10/2022 - 01/2020
3	Vasodilator Agents (Vasodilators)IBA 12/2021 - 08/2007
3	Sodium-Glucose Transport ProteinsIBA 11/2021 - 10/2020
3	RNA (Ribonucleic Acid)IBA 11/2020 - 01/2019
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2017 - 03/2013
3	CholesterolIBA 08/2017 - 08/2002
2	Peptides (Polypeptides)IBA 01/2022 - 01/2018
2	DiureticsIBA 01/2022 - 01/2018
2	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 12/2007
2	Neprilysin (Neutral Endopeptidase)IBA 11/2021 - 01/2018
2	Green Fluorescent ProteinsIBA 11/2020 - 04/2008
2	paragonIBA 11/2020 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2019 - 08/2005
2	AntibodiesIBA 01/2018 - 01/2012
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 12/2017 - 02/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2017 - 06/2012
2	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2017 - 12/2016
2	Troponin IIBA 01/2015 - 10/2007
2	Dobutamine FDA LinkGeneric 01/2013 - 08/2002
2	GadoliniumIBA 10/2012 - 10/2010
2	erucylphosphocholineIBA 05/2010 - 04/2008
2	oxidized low density lipoproteinIBA 10/2002 - 08/2002
1	Immune Checkpoint InhibitorsIBA 10/2022
1	3,5-diisopropylsalicylic acid (DIPS)IBA 08/2022
1	vinyltriethoxysilane (VTES)IBA 03/2022
1	Factor Xa (Coagulation Factor Xa)IBA 01/2022
1	antineoplaston A10 (A 10)IBA 01/2022
1	Digoxin (Digitek)FDA LinkGeneric 01/2022
1	Mineralocorticoid Receptor AntagonistsIBA 01/2022
1	fibrin fragment D (D-dimer)IBA 06/2021

Therapy/Procedure

24	Therapeutics 01/2022 - 01/2006
4	Stents 01/2016 - 06/2002
3	Ligation 08/2017 - 08/2009
2	Heart-Assist Devices 01/2022 - 01/2021
2	Resuscitation 01/2020 - 01/2009
2	Denervation 12/2017 - 01/2014
2	Percutaneous Coronary Intervention 04/2014 - 01/2006
2	Drug Therapy (Chemotherapy) 06/2012 - 05/2005